Natco Pharma Q4 Results Live : profit rise by 40.07% YOY
₹21.56 for Q4, which increased by 42.79% Y-o-Y.Natco Pharma has delivered 3% return in the last 1 week, 31.9% return in the last 6 months, and 26.87% YTD return.Currently, Natco Pharma has a market cap of ₹18437.57 Cr and a 52wk high/low of ₹1108.35 & ₹615.5 respectively.As of 28 May, 2024, out of 9 analysts covering the company, 1 analyst has given a Strong Sell rating, 1 analyst has given a Sell rating, 1 analyst has given a Hold rating, 4 analysts have given a Buy rating, and 2 analysts have given a Strong Buy rating.The consensus recommendation as of 28 May, 2024, was to Buy.FAQsQuestion : What is the Q4 profit/Loss as per company?Ans : ₹386.3CrQuestion : What is Q4 revenue?Ans : ₹1068.3CrStay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
